Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MIMEDX GROUP, INC. Director's Dealing 2022

Sep 19, 2022

32206_dirs_2022-09-19_ed9dad01-96a4-40e2-bb8c-6fcd00e9f2ff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MIMEDX GROUP, INC. (MDXG)
CIK: 0001376339
Period of Report: 2022-09-15

Reporting Person: Newton Todd (Director, Interim CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-09-15 Common Stock A 200000 Acquired 325618 Direct

Footnotes

F1: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests on the one-year anniversary of the grant date, subject to the terms and conditions described in the Restricted Stock Unit Agreement.